{"hands_on_practices": [{"introduction": "A cornerstone of PBPK modeling is quantifying the fraction of drug in plasma that is not bound to proteins, known as the fraction unbound ($f_u$), as this is the portion available for therapeutic action and elimination. This exercise guides you through the derivation of the standard approximation for $f_u$ from the law of mass action, emphasizing a critical assumption used in pharmacokinetics. By calculating $f_u$ for a hypothetical drug, you will solidify your understanding of how protein binding is parameterized in PBPK models [@problem_id:4576225].", "problem": "In Physiologically-Based Pharmacokinetic (PBPK) modeling, the fraction unbound in plasma, denoted $f_u$, is the ratio of the free (not protein-bound) drug concentration to the total drug concentration in plasma. Consider a drug that binds reversibly to human serum albumin via a single class of identical, non-cooperative sites. The binding is governed by the law of mass action at equilibrium. Let $K_a$ be the equilibrium association constant defined by $K_a = \\dfrac{[DA]}{[D][A]}$, where $[D]$ is the free drug concentration, $[A]$ is the free albumin concentration, and $[DA]$ is the drug–albumin complex concentration. Let $[D]_{\\text{tot}}$ and $[A]_{\\text{tot}}$ be the total concentrations of drug and albumin, respectively, with conservation $[D]_{\\text{tot}} = [D] + [DA]$ and $[A]_{\\text{tot}} = [A] + [DA]$.\n\nStarting from these fundamental relationships, derive an approximate expression for $f_u$ under scientifically justified conditions appropriate to plasma (state clearly the assumptions required for the approximation). Then, using realistic values $K_a = 1.50 \\times 10^{5}\\,\\mathrm{M^{-1}}$ and $[A]_{\\text{tot}} = 0.60\\,\\mathrm{mmol\\,L^{-1}}$, compute the numerical value of $f_u$. Round your numerical answer to four significant figures. Express the final $f_u$ as a pure number without units.", "solution": "The problem requires the derivation of an approximate expression for the fraction of unbound drug in plasma, $f_u$, and its numerical calculation based on provided parameters. The process begins with the fundamental definitions and principles of equilibrium binding.\n\nThe fraction unbound, $f_u$, is defined as the ratio of the free drug concentration, $[D]$, to the total drug concentration, $[D]_{\\text{tot}}$:\n$$\nf_u = \\frac{[D]}{[D]_{\\text{tot}}}\n$$\nThe total drug concentration is the sum of the free drug concentration and the concentration of the drug-albumin complex, $[DA]$:\n$$\n[D]_{\\text{tot}} = [D] + [DA]\n$$\nSubstituting this into the definition of $f_u$:\n$$\nf_u = \\frac{[D]}{[D] + [DA]}\n$$\nDividing the numerator and the denominator by $[D]$ yields:\n$$\nf_u = \\frac{1}{1 + \\frac{[DA]}{[D]}}\n$$\nThe binding process is governed by the law of mass action at equilibrium, with an association constant $K_a$:\n$$\nK_a = \\frac{[DA]}{[D][A]}\n$$\nwhere $[A]$ is the free albumin concentration. From this relationship, we can express the ratio $\\frac{[DA]}{[D]}$ as:\n$$\n\\frac{[DA]}{[D]} = K_a [A]\n$$\nSubstituting this into the expression for $f_u$ gives an exact relationship between $f_u$ and the free albumin concentration $[A]$:\n$$\nf_u = \\frac{1}{1 + K_a [A]}\n$$\nThis expression is exact but not directly useful, as $[A]$ itself depends on the extent of binding. To obtain an approximate and more practical expression, we must introduce a scientifically justified assumption relevant to typical physiological and pharmacological conditions.\n\nThe key assumption is that the total drug concentration is much smaller than the total albumin concentration:\n$$\n[D]_{\\text{tot}} \\ll [A]_{\\text{tot}}\n$$\nThis assumption is generally valid in pharmacokinetics. The total concentration of albumin in human plasma, $[A]_{\\text{tot}}$, is typically high (around $0.6\\,\\mathrm{mmol\\,L^{-1}}$ or $600\\,\\mathrm{\\mu M}$). In contrast, therapeutic concentrations of most drugs, $[D]_{\\text{tot}}$, are in the nanomolar ($10^{-9}\\,\\mathrm{M}$) to micromolar ($10^{-6}\\,\\mathrm{M}$) range, which is several orders of magnitude lower.\n\nThe concentration of the drug-albumin complex, $[DA]$, is by definition less than or equal to the total drug concentration, i.e., $[DA] \\le [D]_{\\text{tot}}$. Therefore, the assumption $[D]_{\\text{tot}} \\ll [A]_{\\text{tot}}$ implies that $[DA] \\ll [A]_{\\text{tot}}$.\n\nThe total albumin concentration, $[A]_{\\text{tot}}$, is given by the sum of the free albumin concentration, $[A]$, and the bound albumin concentration, which is equal to $[DA]$:\n$$\n[A]_{\\text{tot}} = [A] + [DA]\n$$\nSince we have established that $[DA] \\ll [A]_{\\text{tot}}$ under our assumption, the concentration of free albumin can be approximated as being equal to the total albumin concentration:\n$$\n[A] = [A]_{\\text{tot}} - [DA] \\approx [A]_{\\text{tot}}\n$$\nSubstituting this approximation into the exact expression for $f_u$ yields the desired approximate expression:\n$$\nf_u \\approx \\frac{1}{1 + K_a [A]_{\\text{tot}}}\n$$\nThis expression is widely used in pharmacology because it shows that for low drug concentrations, the fraction unbound is approximately constant and independent of the drug concentration itself.\n\nNow, we compute the numerical value of $f_u$ using the provided data:\n- Association constant, $K_a = 1.50 \\times 10^{5}\\,\\mathrm{M^{-1}}$.\n- Total albumin concentration, $[A]_{\\text{tot}} = 0.60\\,\\mathrm{mmol\\,L^{-1}}$.\n\nFirst, we must ensure the units are consistent. The unit of $K_a$ is $\\mathrm{M^{-1}}$, so $[A]_{\\text{tot}}$ must be expressed in $\\mathrm{M}$ (which is $\\mathrm{mol\\,L^{-1}}$).\n$$\n[A]_{\\text{tot}} = 0.60\\,\\mathrm{mmol\\,L^{-1}} = 0.60 \\times 10^{-3}\\,\\mathrm{mol\\,L^{-1}} = 6.0 \\times 10^{-4}\\,\\mathrm{M}\n$$\nNext, we calculate the dimensionless product $K_a [A]_{\\text{tot}}$:\n$$\nK_a [A]_{\\text{tot}} = (1.50 \\times 10^{5}\\,\\mathrm{M^{-1}}) \\times (6.0 \\times 10^{-4}\\,\\mathrm{M})\n$$\n$$\nK_a [A]_{\\text{tot}} = (1.50 \\times 6.0) \\times (10^{5} \\times 10^{-4}) = 9.0 \\times 10^{1} = 90\n$$\nNow we substitute this value back into the approximate expression for $f_u$:\n$$\nf_u \\approx \\frac{1}{1 + 90} = \\frac{1}{91}\n$$\nTo obtain the final numerical answer, we compute the value of this fraction and round it to four significant figures as requested:\n$$\nf_u \\approx 0.0109890109...\n$$\nRounding to four significant figures gives:\n$$\nf_u \\approx 0.01099\n$$\nThis value represents that approximately $1.099\\%$ of the drug in plasma is free and available to interact with its pharmacological target.", "answer": "$$\\boxed{0.01099}$$", "id": "4576225"}, {"introduction": "Predicting how a drug distributes into various tissues is a central task of PBPK modeling, directly influencing its volume of distribution ($V_{\\text{ss}}$). This practice illustrates how to calculate tissue-to-plasma partition coefficients ($K_p$) for different organs by treating them as mixtures of water, neutral lipids, and phospholipids, using the drug's lipophilicity ($\\log P$) as a key input. You will then integrate these $K_p$ values with physiological organ volumes to predict the overall $V_{\\text{ss}}$, providing a foundational skill in bottom-up PBPK model construction [@problem_id:4576232].", "problem": "A neutral small-molecule drug with octanol–water partition coefficient characterized by $\\log P = 3.0$ is being evaluated using a simplified composition-based Physiologically-Based Pharmacokinetic (PBPK) modeling framework. The drug is assumed to be unionized at physiological pH and to bind negligibly to proteins in both plasma and tissues. At distribution equilibrium, the tissue-to-plasma partition coefficient $K_p$ is determined by additive partitioning into water, neutral lipids, and phospholipids. The neutral lipid–water partition scaling is taken to be proportional to the octanol–water partition coefficient $P$, and the phospholipid–water partition scaling is taken to be a fixed fraction $\\alpha$ of $P$. Specifically, use $P = 10^{\\log P}$ and $\\alpha = 0.3$. Red blood cell to plasma partitioning is assumed to be unity.\n\nUse the following volume fractions for water, neutral lipids, and phospholipids in each matrix:\n- Plasma: $f_{\\mathrm{w,p}} = 0.945$, $f_{\\mathrm{nl,p}} = 0.003$, $f_{\\mathrm{np,p}} = 0.012$.\n- Liver: $f_{\\mathrm{w,liv}} = 0.68$, $f_{\\mathrm{nl,liv}} = 0.05$, $f_{\\mathrm{np,liv}} = 0.17$.\n- Adipose: $f_{\\mathrm{w,ad}} = 0.14$, $f_{\\mathrm{nl,ad}} = 0.79$, $f_{\\mathrm{np,ad}} = 0.02$.\n\nConsider a $70$ $\\mathrm{kg}$ adult modeled as plasma, liver, and adipose compartments with the following volumes:\n- Plasma volume $V_{\\mathrm{p}} = 3.0$ $\\mathrm{L}$,\n- Liver volume $V_{\\mathrm{liv}} = 1.8$ $\\mathrm{L}$,\n- Adipose volume $V_{\\mathrm{ad}} = 21.0$ $\\mathrm{L}$.\n\nStarting from first principles of distribution equilibria between plasma and tissues across the three constituent phases (water, neutral lipids, phospholipids), derive expressions for the liver and adipose tissue partition coefficients $K_{p,\\mathrm{liv}}$ and $K_{p,\\mathrm{ad}}$ in terms of the given quantities, compute their numerical values, and then use them to compute the steady-state volume of distribution $V_{\\mathrm{ss}}$ for the whole body under the assumption that only these three compartments contribute. Express your final numerical answer for $V_{\\mathrm{ss}}$ in $\\mathrm{L}$ and round to three significant figures. Do not report intermediate results; only report the final $V_{\\mathrm{ss}}$ value as your answer.", "solution": "The core task is to compute the steady-state volume of distribution, $V_{\\mathrm{ss}}$, which requires deriving the tissue-to-plasma partition coefficients, $K_p$, from first principles.\n\nThe tissue-to-plasma partition coefficient, $K_{p,T}$, for a given tissue $T$ is defined as the ratio of the total drug concentration in that tissue, $C_T$, to the total drug concentration in plasma, $C_P$, at distribution equilibrium:\n$$K_{p,T} = \\frac{C_T}{C_P}$$\nThe total concentration in any compartment (tissue or plasma) is the sum of concentrations in its constituent phases: water (w), neutral lipids (nl), and phospholipids (np). The total concentration, $C$, in a compartment with volume fractions $f_{\\mathrm{w}}$, $f_{\\mathrm{nl}}$, and $f_{\\mathrm{np}}$ can be expressed as:\n$$C = C_{\\mathrm{w}}f_{\\mathrm{w}} + C_{\\mathrm{nl}}f_{\\mathrm{nl}} + C_{\\mathrm{np}}f_{\\mathrm{np}}$$\nwhere $C_{\\mathrm{w}}$, $C_{\\mathrm{nl}}$, and $C_{\\mathrm{np}}$ are the drug concentrations in the water, neutral lipid, and phospholipid phases, respectively.\n\nThe partitioning of the drug from the aqueous phase into the lipid phases is described by partition coefficients. The neutral lipid-to-water partition coefficient is $K_{\\mathrm{nl/w}} = C_{\\mathrm{nl}}/C_{\\mathrm{w}}$, and the phospholipid-to-water partition coefficient is $K_{\\mathrm{pl/w}} = C_{\\mathrm{np}}/C_{\\mathrm{w}}$. The problem specifies that for this neutral, unionized drug, these are functions of the octanol-water partition coefficient, $P$. We assume the direct proportionality: $K_{\\mathrm{nl/w}} = P$ and $K_{\\mathrm{pl/w}} = \\alpha P$.\nTherefore, we can express the lipid phase concentrations in terms of the aqueous phase concentration: $C_{\\mathrm{nl}} = P \\cdot C_{\\mathrm{w}}$ and $C_{\\mathrm{np}} = \\alpha P \\cdot C_{\\mathrm{w}}$.\n\nSubstituting these into the expression for total concentration $C$:\n$$C = C_{\\mathrm{w}}f_{\\mathrm{w}} + (P \\cdot C_{\\mathrm{w}})f_{\\mathrm{nl}} + (\\alpha P \\cdot C_{\\mathrm{w}})f_{\\mathrm{np}} = C_{\\mathrm{w}}(f_{\\mathrm{w}} + P f_{\\mathrm{nl}} + \\alpha P f_{\\mathrm{np}})$$\nThis general relationship applies to both tissue and plasma. For a tissue $T$ and for plasma $p$:\n$$C_T = C_{\\mathrm{w},T}(f_{\\mathrm{w},T} + P f_{\\mathrm{nl},T} + \\alpha P f_{\\mathrm{np},T})$$\n$$C_p = C_{\\mathrm{w},p}(f_{\\mathrm{w},p} + P f_{\\mathrm{nl},p} + \\alpha P f_{\\mathrm{np},p})$$\nAt distribution equilibrium for a neutral drug that is not a substrate for transporters and has negligible protein binding, the concentration of the drug in the aqueous phase is uniform across all compartments. Therefore, $C_{\\mathrm{w},T} = C_{\\mathrm{w},p}$.\n\nSubstituting these expressions into the definition of $K_{p,T}$ and canceling the common $C_{\\mathrm{w}}$ term yields the final expression for the tissue-to-plasma partition coefficient:\n$$K_{p,T} = \\frac{f_{\\mathrm{w},T} + P f_{\\mathrm{nl},T} + \\alpha P f_{\\mathrm{np},T}}{f_{\\mathrm{w},p} + P f_{\\mathrm{nl},p} + \\alpha P f_{\\mathrm{np},p}}$$\nThe steady-state volume of distribution, $V_{\\mathrm{ss}}$, is calculated by summing the volumes of all model compartments, each weighted by its respective partition coefficient. Since the partition coefficient of plasma to plasma is $K_{p,p} = 1$, the formula for the three-compartment model is:\n$$V_{\\mathrm{ss}} = V_{\\mathrm{p}} \\cdot K_{p,p} + V_{\\mathrm{liv}} \\cdot K_{p,\\mathrm{liv}} + V_{\\mathrm{ad}} \\cdot K_{p,\\mathrm{ad}} = V_{\\mathrm{p}} + V_{\\mathrm{liv}} K_{p,\\mathrm{liv}} + V_{\\mathrm{ad}} K_{p,\\mathrm{ad}}$$\n\nWe are given the following values:\n$\\log P = 3.0$, so $P = 10^{3.0} = 1000$.\n$\\alpha = 0.3$.\nPlasma composition: $f_{\\mathrm{w,p}} = 0.945$, $f_{\\mathrm{nl,p}} = 0.003$, $f_{\\mathrm{np,p}} = 0.012$.\nLiver composition: $f_{\\mathrm{w,liv}} = 0.68$, $f_{\\mathrm{nl,liv}} = 0.05$, $f_{\\mathrm{np,liv}} = 0.17$.\nAdipose composition: $f_{\\mathrm{w,ad}} = 0.14$, $f_{\\mathrm{nl,ad}} = 0.79$, $f_{\\mathrm{np,ad}} = 0.02$.\nCompartment volumes: $V_{\\mathrm{p}} = 3.0$ $\\mathrm{L}$, $V_{\\mathrm{liv}} = 1.8$ $\\mathrm{L}$, $V_{\\mathrm{ad}} = 21.0$ $\\mathrm{L}$.\n\nFirst, we calculate the denominator, which is constant for all $K_p$ calculations:\n$$\\text{Denominator} = f_{\\mathrm{w,p}} + P f_{\\mathrm{nl,p}} + \\alpha P f_{\\mathrm{np,p}}$$\n$$\\text{Denominator} = 0.945 + (1000)(0.003) + (0.3)(1000)(0.012) = 0.945 + 3.0 + 3.6 = 7.545$$\nNext, we calculate $K_{p,\\mathrm{liv}}$:\n$$K_{p,\\mathrm{liv}} = \\frac{f_{\\mathrm{w,liv}} + P f_{\\mathrm{nl,liv}} + \\alpha P f_{\\mathrm{np,liv}}}{\\text{Denominator}}$$\n$$K_{p,\\mathrm{liv}} = \\frac{0.68 + (1000)(0.05) + (0.3)(1000)(0.17)}{7.545} = \\frac{0.68 + 50 + 51}{7.545} = \\frac{101.68}{7.545}$$\nThen, we calculate $K_{p,\\mathrm{ad}}$:\n$$K_{p,\\mathrm{ad}} = \\frac{f_{\\mathrm{w,ad}} + P f_{\\mathrm{nl,ad}} + \\alpha P f_{\\mathrm{np,ad}}}{\\text{Denominator}}$$\n$$K_{p,\\mathrm{ad}} = \\frac{0.14 + (1000)(0.79) + (0.3)(1000)(0.02)}{7.545} = \\frac{0.14 + 790 + 6}{7.545} = \\frac{796.14}{7.545}$$\nFinally, we compute $V_{\\mathrm{ss}}$:\n$$V_{\\mathrm{ss}} = V_{\\mathrm{p}} + V_{\\mathrm{liv}} K_{p,\\mathrm{liv}} + V_{\\mathrm{ad}} K_{p,\\mathrm{ad}}$$\n$$V_{\\mathrm{ss}} = 3.0 + (1.8) \\left( \\frac{101.68}{7.545} \\right) + (21.0) \\left( \\frac{796.14}{7.545} \\right)$$\n$$V_{\\mathrm{ss}} = 3.0 + \\frac{183.024}{7.545} + \\frac{16718.94}{7.545}$$\n$$V_{\\mathrm{ss}} \\approx 3.0 + 24.25765 + 2215.89993$$\n$$V_{\\mathrm{ss}} \\approx 2243.15758$$\nThe problem requires the final answer to be rounded to three significant figures.\n$$V_{\\mathrm{ss}} \\approx 2240$$\nIn scientific notation, this is $2.24 \\times 10^3$.", "answer": "$$\\boxed{2.24 \\times 10^{3}}$$", "id": "4576232"}, {"introduction": "Understanding how physiological changes affect drug elimination is a key application of PBPK modeling, enabling prediction of drug behavior in disease states. This exercise challenges you to use the well-stirred model of hepatic clearance to analyze how a reduction in blood flow impacts drugs with different extraction characteristics. By exploring the distinct behaviors of low- and high-extraction compounds, you will gain critical insight into flow-limited versus capacity-limited clearance and its consequences for drug exposure [@problem_id:4576247].", "problem": "Consider a single-organ liver within a Physiologically-Based Pharmacokinetic (PBPK) model under the well-stirred assumption: the liver behaves as a perfectly mixed compartment, elimination is driven by the unbound drug in the liver, and binding within blood is at rapid equilibrium. Let hepatic blood flow be denoted by $Q_{h}$, the hepatic extraction ratio by $E_{h}$, the hepatic clearance by $CL_{h}$, the fraction unbound in blood by $f_{u}$, and the intrinsic hepatic clearance by $CL_{\\mathrm{int}}$.\n\nUse fundamental mass balance and core definitions to derive how $CL_{h}$ depends on $Q_{h}$, $f_{u}$, and $CL_{\\mathrm{int}}$. Then, using limiting-case analysis, characterize the low-extraction regime ($f_{u} \\, CL_{\\mathrm{int}} \\ll Q_{h}$) and the high-extraction regime ($f_{u} \\, CL_{\\mathrm{int}} \\gg Q_{h}$).\n\nNow consider an adult patient with heart failure that reduces hepatic blood flow by $30$ percent, so the new hepatic blood flow is $Q_{h}' = (1 - 0.30)\\, Q_{h}$. Assume linear pharmacokinetics and an intravenous bolus dose $D$ is administered, so that the area under the plasma concentration–time curve (AUC) satisfies the definition $\\mathrm{AUC} = D / CL$, where $CL$ is the systemic clearance and hepatic clearance is the dominant component of $CL$ for both drugs considered.\n\nCompute, for each regime (low extraction and high extraction), the ratio of the new to baseline hepatic clearance and the ratio of the new to baseline $\\mathrm{AUC}$:\n- $R_{\\mathrm{CL},\\mathrm{low}} = CL_{h}' / CL_{h}$,\n- $R_{\\mathrm{AUC},\\mathrm{low}} = \\mathrm{AUC}' / \\mathrm{AUC}$,\n- $R_{\\mathrm{CL},\\mathrm{high}} = CL_{h}' / CL_{h}$,\n- $R_{\\mathrm{AUC},\\mathrm{high}} = \\mathrm{AUC}' / \\mathrm{AUC}$.\n\nReport, in order, the four ratios $R_{\\mathrm{CL},\\mathrm{low}}$, $R_{\\mathrm{AUC},\\mathrm{low}}$, $R_{\\mathrm{CL},\\mathrm{high}}$, $R_{\\mathrm{AUC},\\mathrm{high}}$. Express these four ratios as dimensionless quantities and round your answer to $4$ significant figures.", "solution": "The problem requires the derivation of the hepatic clearance equation under the well-stirred model, followed by a limiting-case analysis to determine the impact of reduced hepatic blood flow on drug clearance and exposure for low- and high-extraction drugs.\n\nFirst, we derive the relationship for hepatic clearance, $CL_h$, as a function of hepatic blood flow ($Q_h$), fraction unbound in blood ($f_u$), and intrinsic hepatic clearance ($CL_{\\mathrm{int}}$).\n\nUnder steady-state conditions, the rate of drug elimination in the liver is the difference between the rate of drug entry and the rate of drug exit. Let $C_{\\mathrm{in}}$ be the drug concentration in the blood entering the liver and $C_{\\mathrm{out}}$ be the drug concentration in the blood leaving the liver.\nThe rate of drug entry is $Q_h C_{\\mathrm{in}}$.\nThe rate of drug exit is $Q_h C_{\\mathrm{out}}$.\nThe rate of elimination is therefore:\n$$ \\text{Rate of Elimination} = Q_h C_{\\mathrm{in}} - Q_h C_{\\mathrm{out}} = Q_h (C_{\\mathrm{in}} - C_{\\mathrm{out}}) $$\n\nHepatic clearance, $CL_h$, is defined as the rate of elimination divided by the entering drug concentration:\n$$ CL_h = \\frac{\\text{Rate of Elimination}}{C_{\\mathrm{in}}} = \\frac{Q_h (C_{\\mathrm{in}} - C_{\\mathrm{out}})}{C_{\\mathrm{in}}} $$\nThis can be expressed in terms of the hepatic extraction ratio, $E_h = \\frac{C_{\\mathrm{in}} - C_{\\mathrm{out}}}{C_{\\mathrm{in}}}$, as:\n$$ CL_h = Q_h E_h $$\n\nThe well-stirred model assumes that the liver is a single, well-mixed compartment. This implies that the drug concentration throughout the liver tissue is uniform and equal to the concentration in the exiting blood, $C_{\\mathrm{out}}$. Elimination is driven by the unbound drug concentration in the liver. With the assumption of rapid binding equilibrium, the unbound concentration in the liver is equal to the unbound concentration in the exiting blood, which is $f_u C_{\\mathrm{out}}$.\n\nThe rate of elimination can also be expressed in terms of the intrinsic clearance, $CL_{\\mathrm{int}}$, which is defined as the maximum clearance capacity of the liver enzymes, independent of blood flow. It relates the rate of elimination to the unbound drug concentration at the enzyme site:\n$$ \\text{Rate of Elimination} = CL_{\\mathrm{int}} \\times (\\text{unbound concentration in liver}) = CL_{\\mathrm{int}} (f_u C_{\\mathrm{out}}) $$\n\nBy equating the two expressions for the rate of elimination, we can solve for the relationship between the parameters:\n$$ Q_h (C_{\\mathrm{in}} - C_{\\mathrm{out}}) = f_u CL_{\\mathrm{int}} C_{\\mathrm{out}} $$\nTo find $E_h$, we rearrange this equation to solve for the ratio $C_{\\mathrm{out}}/C_{\\mathrm{in}}$:\n$$ Q_h C_{\\mathrm{in}} = Q_h C_{\\mathrm{out}} + f_u CL_{\\mathrm{int}} C_{\\mathrm{out}} $$\n$$ Q_h C_{\\mathrm{in}} = (Q_h + f_u CL_{\\mathrm{int}}) C_{\\mathrm{out}} $$\n$$ \\frac{C_{\\mathrm{out}}}{C_{\\mathrm{in}}} = \\frac{Q_h}{Q_h + f_u CL_{\\mathrm{int}}} $$\nThe extraction ratio $E_h$ is $1 - C_{\\mathrm{out}}/C_{\\mathrm{in}}$:\n$$ E_h = 1 - \\frac{Q_h}{Q_h + f_u CL_{\\mathrm{int}}} = \\frac{(Q_h + f_u CL_{\\mathrm{int}}) - Q_h}{Q_h + f_u CL_{\\mathrm{int}}} = \\frac{f_u CL_{\\mathrm{int}}}{Q_h + f_u CL_{\\mathrm{int}}} $$\nFinally, substituting this expression for $E_h$ into the equation $CL_h = Q_h E_h$, we obtain the well-stirred model equation for hepatic clearance:\n$$ CL_h = Q_h \\left( \\frac{f_u CL_{\\mathrm{int}}}{Q_h + f_u CL_{\\mathrm{int}}} \\right) $$\n\nNext, we perform a limiting-case analysis.\n\nLow-Extraction Regime ($f_u CL_{\\mathrm{int}} \\ll Q_h$):\nIn this case, the term $f_u CL_{\\mathrm{int}}$ in the denominator is negligible compared to $Q_h$. Therefore, $Q_h + f_u CL_{\\mathrm{int}} \\approx Q_h$.\nThe hepatic clearance simplifies to:\n$$ CL_{h, \\mathrm{low}} \\approx Q_h \\left( \\frac{f_u CL_{\\mathrm{int}}}{Q_h} \\right) = f_u CL_{\\mathrm{int}} $$\nIn this regime, clearance is independent of hepatic blood flow $Q_h$ and depends primarily on protein binding ($f_u$) and enzyme activity ($CL_{\\mathrm{int}}$). This is known as \"capacity-limited\" clearance.\n\nHigh-Extraction Regime ($f_u CL_{\\mathrm{int}} \\gg Q_h$):\nIn this case, $Q_h$ is negligible compared to $f_u CL_{\\mathrm{int}}$ in the denominator. Therefore, $Q_h + f_u CL_{\\mathrm{int}} \\approx f_u CL_{\\mathrm{int}}$.\nThe hepatic clearance simplifies to:\n$$ CL_{h, \\mathrm{high}} \\approx Q_h \\left( \\frac{f_u CL_{\\mathrm{int}}}{f_u CL_{\\mathrm{int}}} \\right) = Q_h $$\nIn this regime, clearance is approximately equal to the hepatic blood flow $Q_h$, and is independent of protein binding and enzyme activity. This is known as \"flow-limited\" or \"perfusion-limited\" clearance.\n\nNow, we analyze the effect of a $30\\%$ reduction in hepatic blood flow, $Q_h' = (1 - 0.30)Q_h = 0.70 Q_h$. We assume $CL_{\\mathrm{int}}$ and $f_u$ are unchanged. The area under the plasma concentration-time curve (AUC) is given by $\\mathrm{AUC} = D/CL$. Since hepatic clearance is the dominant component of systemic clearance, we approximate $CL \\approx CL_h$. The ratio of new to baseline AUC is $\\mathrm{AUC}'/\\mathrm{AUC} = (D/CL_h') / (D/CL_h) = CL_h/CL_h'$.\n\nFor the low-extraction regime:\nThe baseline clearance is $CL_{h, \\mathrm{low}} \\approx f_u CL_{\\mathrm{int}}$.\nThe new clearance is $CL_{h, \\mathrm{low}}' \\approx f_u CL_{\\mathrm{int}}$ (since it is independent of $Q_h$).\nThe ratio of clearances is:\n$$ R_{\\mathrm{CL},\\mathrm{low}} = \\frac{CL_{h, \\mathrm{low}}'}{CL_{h, \\mathrm{low}}} = \\frac{f_u CL_{\\mathrm{int}}}{f_u CL_{\\mathrm{int}}} = 1 $$\nThe ratio of AUCs is:\n$$ R_{\\mathrm{AUC},\\mathrm{low}} = \\frac{\\mathrm{AUC}_{\\mathrm{low}}'}{\\mathrm{AUC}_{\\mathrm{low}}} = \\frac{CL_{h, \\mathrm{low}}}{CL_{h, \\mathrm{low}}'} = \\frac{1}{R_{\\mathrm{CL},\\mathrm{low}}} = 1 $$\n\nFor the high-extraction regime:\nThe baseline clearance is $CL_{h, \\mathrm{high}} \\approx Q_h$.\nThe new clearance is $CL_{h, \\mathrm{high}}' \\approx Q_h' = 0.70 Q_h$.\nThe ratio of clearances is:\n$$ R_{\\mathrm{CL},\\mathrm{high}} = \\frac{CL_{h, \\mathrm{high}}'}{CL_{h, \\mathrm{high}}} = \\frac{0.70 Q_h}{Q_h} = 0.70 $$\nThe ratio of AUCs is:\n$$ R_{\\mathrm{AUC},\\mathrm{high}} = \\frac{\\mathrm{AUC}_{\\mathrm{high}}'}{\\mathrm{AUC}_{\\mathrm{high}}} = \\frac{CL_{h, \\mathrm{high}}}{CL_{h, \\mathrm{high}}'} = \\frac{1}{R_{\\mathrm{CL},\\mathrm{high}}} = \\frac{1}{0.70} = \\frac{10}{7} $$\n\nFinally, we express the four ratios as dimensionless quantities rounded to $4$ significant figures.\n$R_{\\mathrm{CL},\\mathrm{low}} = 1.000$\n$R_{\\mathrm{AUC},\\mathrm{low}} = 1.000$\n$R_{\\mathrm{CL},\\mathrm{high}} = 0.7000$\n$R_{\\mathrm{AUC},\\mathrm{high}} = \\frac{10}{7} \\approx 1.428571... \\approx 1.429$\n\nThe four ratios, in order, are $1.000$, $1.000$, $0.7000$, and $1.429$.", "answer": "$$ \\boxed{ \\begin{pmatrix} 1.000 & 1.000 & 0.7000 & 1.429 \\end{pmatrix} } $$", "id": "4576247"}]}